未找到相关数据
Denosumab in postmenopausal women with low bone mineral density
被引：3
作者：
Charles L. Loprinzi
机构：
关键词：
Bone Mineral Density;
Alendronate;
Distal Radius;
Denosumab;
Lumbosacral Spine;
D O I：
10.1007/s11912-006-0031-7
中图分类号：
学科分类号：
摘要：
This study demonstrated that various doses of denosumab, given subcutaneously at 3- or 6-month intervals, were well tolerated, markedly reduced measures of bone turnover, and led to improvements in bone densities at the lumbosacral spine, hip, and distal radius.
引用
收藏
页码：267 / 268
页数：1
相关论文